These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18045062)

  • 21. Focal adhesion kinase signaling - tumor vulnerabilities and clinical opportunities.
    Schlaepfer DD; Ojalill M; Stupack DG
    J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 39034922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FAK signaling in human cancer as a target for therapeutics.
    Lee BY; Timpson P; Horvath LG; Daly RJ
    Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271.
    Roberts WG; Ung E; Whalen P; Cooper B; Hulford C; Autry C; Richter D; Emerson E; Lin J; Kath J; Coleman K; Yao L; Martinez-Alsina L; Lorenzen M; Berliner M; Luzzio M; Patel N; Schmitt E; LaGreca S; Jani J; Wessel M; Marr E; Griffor M; Vajdos F
    Cancer Res; 2008 Mar; 68(6):1935-44. PubMed ID: 18339875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.
    Hao HF; Takaoka M; Bao XH; Wang ZG; Tomono Y; Sakurama K; Ohara T; Fukazawa T; Yamatsuji T; Fujiwara T; Naomoto Y
    Biochem Biophys Res Commun; 2012 Jul; 423(4):744-9. PubMed ID: 22705303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FAK inhibitors in cancer, a patent review - an update on progress.
    Ye YX; Cao YY; Xu LS; Wang HC; Liu XH; Zhu HL
    Expert Opin Ther Pat; 2024 Aug; 34(8):593-610. PubMed ID: 38946486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Silencing of focal adhesion kinase by tumor direct injection of small interfering RNA decreases in vivo tumor growth.
    Tsutsumi K; Yamaura T; Nakajima M; Honda T; Kasaoka T
    Cancer Biol Ther; 2009 Jul; 8(13):1292-9. PubMed ID: 19458494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Focal adhesion kinase: exploring Fak structure to gain insight into function.
    Hall JE; Fu W; Schaller MD
    Int Rev Cell Mol Biol; 2011; 288():185-225. PubMed ID: 21482413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal adhesion kinase: a promising target for anticancer therapy.
    Chatzizacharias NA; Kouraklis GP; Theocharis SE
    Expert Opin Ther Targets; 2007 Oct; 11(10):1315-28. PubMed ID: 17907961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules.
    Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD
    Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal adhesion kinase.
    Zachary I
    Int J Biochem Cell Biol; 1997 Jul; 29(7):929-34. PubMed ID: 9375372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal adhesion kinase as a target in the treatment of hematological malignancies.
    Yin B
    Leuk Res; 2011 Oct; 35(10):1416-8. PubMed ID: 21592572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of motile and invasive cell phenotypes by focal adhesion kinase.
    Schlaepfer DD; Mitra SK; Ilic D
    Biochim Biophys Acta; 2004 Jul; 1692(2-3):77-102. PubMed ID: 15246681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
    Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The focal adhesion kinase--a regulator of cell migration and invasion.
    Hauck CR; Hsia DA; Schlaepfer DD
    IUBMB Life; 2002 Feb; 53(2):115-9. PubMed ID: 12049193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1.
    Mon NN; Hasegawa H; Thant AA; Huang P; Tanimura Y; Senga T; Hamaguchi M
    Cancer Res; 2006 Jul; 66(13):6778-84. PubMed ID: 16818654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging roles of focal adhesion kinase in cancer.
    Tai YL; Chen LC; Shen TL
    Biomed Res Int; 2015; 2015():690690. PubMed ID: 25918719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
    Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
    Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA interference elucidates the role of focal adhesion kinase in HLA class I-mediated focal adhesion complex formation and proliferation in human endothelial cells.
    Jin YP; Korin Y; Zhang X; Jindra PT; Rozengurt E; Reed EF
    J Immunol; 2007 Jun; 178(12):7911-22. PubMed ID: 17548629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal adhesion kinase as a potential target in oncology.
    McLean GW; Avizienyte E; Frame MC
    Expert Opin Pharmacother; 2003 Feb; 4(2):227-34. PubMed ID: 12562313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.